• Pharmacy technician certification board scoops education council

    The Pharmacy Technician Certification Board acquired the Pharmacy Technician Educators Council Dec. 15 with the hopes of helping pharmacy technicians build their careers and ensure patient safety. 
  • AbbVie leaves 2 pharmaceutical lobbies

    North Chicago, Ill.-based AbbVie is cutting ties with the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization, two leading pharmaceutical lobby groups. 
  • 5th pharmacy worker sentenced for role in deadly meningitis outbreak

    The final defendant in the case of New England Compounding Center, a non-defunct pharmacy that sold moldy steroid drugs made in unsanitary conditions, leading to the deaths of more than 100 people, was sentenced Dec. 13 to five months in prison. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • Despite flu admissions rising, Tamiflu fill rates are on the decline

    As the U.S. reports an 80 percent hospital bed capacity, fill rates for common flu drug Tamiflu have slightly fallen since late November, GoodRx data shows. 
  • Dozens of drugs may increase risk of rare brain infection

    A new study found dozens of FDA approved drugs can increase the risk of developing progressive multifocal leukoencephalopathy, a rare and often fatal brain infection, by an average of eight times.
  • Lawmakers probe Pfizer's planned market price for its COVID-19 vaccine

    Massachusetts Senator Elizabeth Warren and Vermont Representative and Senator-elect Peter Welch sent a letter to Pfizer Dec. 12 to seek reasoning behind the company's proposal to "quadruple" the cost of its COVID-19 vaccine" with "a 10,000 percent markup over what experts estimate as the cost of production."
  • Biogen 19th drugmaker to shirk access in 340B program, nonprofit says

    Biogen, along with 18 other drugmakers, are shortcutting the 340B law by restricting their involvement in the drug pricing program, nonprofit organization 340B Health said Dec. 13. 
  • Top 10 pharma companies by 2021 revenue

    Pfizer nearly doubled its total revenue compared to 2020's list of the top 10 drugmakers, according to Yahoo Finance data. 
  • Study hints at promise of mRNA technology for cancer treatment

    Moderna and Merck scored promising results from their joint project to test the mRNA-based technology used in COVID-19 vaccines combined with cancer drug Keytruda, the two companies said Dec. 13. 
  • 'Patent thickets' are driving up drug costs, Kaiser leader says

    The most popular drugs, on average, have 74 patents each — and these "patent thickets" are "enormous legal fortresses" stomping out competition to keep drug prices high, according to Anthony Barrueta, a senior vice president at Oakland, Calif.-based Kaiser Permanente. 
  • 1st patient to receive base editing gene therapy in remission

    The world's first patient to be infused with base-edited T-cells is in remission for leukemia 28 days after receiving the gene therapy, according to the U.K.-based Great Ormond Street Hospital. 
  • Mpox vaccine reduced infection risk by 9.6 times: CDC

    Among mpox vaccine-eligible men in the U.S., two doses of the Jynneos vaccine reduced the risk of mpox by 9.6 times and one dose reduced the risk by 7.4 times, according to the CDC.
  • Missouri hospital opens specialty pharmacy

    Ozarks Healthcare, a 114-bed hospital based in West Plains, Mo., recently began offering specialty treatments through its pharmacy. 
  • 2022's priciest healthcare acquisition: Amgen to buy Horizon for $27.8B

    Amgen plans to scoop up Horizon Therapeutics for $27.8 billion, which would be the most expensive healthcare acquisition announced in 2022. 
  • Amoxicillin shortage worsens to 44 products, resupply dates pushed to 2023

    The number of amoxicillin products on back order has increased to 44 after months of the antibiotic being out of stock, according to the American Society of Health-System Pharmacists. 
  • Drugs at your door: The growth of home-delivery medications

    The latest trend of delivering vital medications and treatments to people's homes could improve healthcare access and patient outcomes, CNN reported Dec. 8. 
  • Sun Pharma plant may be barred from shipping drugs to US

    Sun Pharmaceuticals' drug manufacturing plant in Gujarat, India, received an import alert from the FDA Dec. 7, which could threaten the drugmakers' ability to ship drugs to the U.S.
  • 7 out of 10 price-hike drugs weren't necessary, ICER finds

    Of the 10 drugs with the biggest price hikes in 2021, seven lacked new clinical evidence to sponsor their growing price tags, according to the Institute for Clinical and Economic Review's annual report. 
  • OTC flu, cold meds in short supply nationwide

    High demand for over-the-counter flu and cold medications such as children's Tylenol, cough syrup and Motrin are leading to nationwide shortages, CBS affiliate WFMY reported Dec. 7. 

Featured Whitepapers

Featured Webinars